11Suppliers
18Customers
3Debt Items
20Related Chains

Source-Backed Evidence Depth

Incannex Healthcare Inc. (IXHL) is shown with relationship data already present in ChainSifter's database. Counts below come from stored supply-chain records and filing/source URLs where available; missing source URLs are not filled in or estimated.

32Total relationships
4Distinct source URLs
9High confidence
0.723Average confidence
2026-09-13Latest database update
ChainSifter does not infer unreported suppliers, customers, ownership, acquisitions, debt exposure, revenue dependency, or future supply-chain events on this public page.

Incannex Healthcare Inc. Suppliers

TickerNameConfidenceEvidence
A-G-P-ALLIANCE-GLOBAL-PARTNERS A-G-P-ALLIANCE-GLOBAL-PARTNERS 90% the Company, Curvature Securities, LLC ('Curvature') and A.G.P./Alliance Global Partners ('A.G.P.' and together with Curvature, the 'Sales Agents')
CONSULTANTS CONSULTANTS 90% Our R&D expenses include: ● external costs incurred under agreements with contract research organizations, contract manufacturers, consultants and other third parties to conduct and support our clini…
CONTRACT-MANUFACTURERS CONTRACT-MANUFACTURERS 90% Our R&D expenses include: ● external costs incurred under agreements with contract research organizations, contract manufacturers, consultants and other third parties to conduct and support our clini…
CONTRACT-RESEARCH-ORGANIZATIONS CONTRACT-RESEARCH-ORGANIZATIONS 90% Our R&D expenses include: ● external costs incurred under agreements with contract research organizations, contract manufacturers, consultants and other third parties to conduct and support our clini…
CURVATURE-SECURITIES-LLC CURVATURE-SECURITIES-LLC 90% the Company, Curvature Securities, LLC ('Curvature') and A.G.P./Alliance Global Partners ('A.G.P.' and together with Curvature, the 'Sales Agents')
MIND-MEDICINE-AUSTRALIA MIND-MEDICINE-AUSTRALIA 80% The Company has a joint venture with Mind Medicine Australia ("MMA") to operate a psychedelic-assisted therapies services clinic in Melbourne, Australia
NVO Novo Nordisk A/S 72% half from providing any bribe, gift or gratuity, including excessive or lavish meals, travel or entertainment in connection with marketing our products and services or securing required permits and a…
NVO Novo Nordisk A/S 72% Reciprocal relationship from NVO graph: Reciprocal relationship from IXHL graph: Reciprocal relationship from NVO graph: Reciprocal relationship from IXHL graph: half from providing any bribe, gift o…
ORANY ORANY 72% notice of the Federal Register publication is forwarded by the DEA to all those registered, or applicants for registration, as bulk manufacturers of that substance. Once registered, manufacturing fac…
ORANY ORANY 72% Reciprocal relationship from ORANY graph: Reciprocal relationship from IXHL graph: notice of the Federal Register publication is forwarded by the DEA to all those registered, or applicants for regist…
ARENA-INVESTORS ARENA-INVESTORS 70% The (i) First Tranche Warrant, (ii) Registration Rights Agreement, dated as of October 14, 2025, by and between the Company and Arena Investors and (iii) ELOC Warrant remained in effect

Incannex Healthcare Inc. Customers

TickerNameConfidenceEvidence
NVO Novo Nordisk A/S 72% ed by the Court of Justice of the European Union (“CJEU”) in its decision on a case known as Schrems II , which invalidated the previous EU-US Privacy Shield. Notably, the new obligations were geared…
NVO Novo Nordisk A/S 72% Reciprocal relationship from NVO graph: Reciprocal relationship from IXHL graph: ed by the Court of Justice of the European Union (“CJEU”) in its decision on a case known as Schrems II , which invali…
ORANY ORANY 72% Reciprocal relationship from ORANY graph: Reciprocal relationship from IXHL graph: Reciprocal relationship from ORANY graph: Reciprocal relationship from IXHL graph: notice of the Federal Register pu…
ORANY ORANY 72% notice of the Federal Register publication is forwarded by the DEA to all those registered, or applicants for registration, as bulk manufacturers of that substance. Once registered, manufacturing fac…
APIRX-PHARMACEUTICALS-HOLDING-BV-IJSSELSTEIN-NET APIRX-PHARMACEUTICALS-HOLDING-BV-IJSSELSTEIN-NET 62% - Total liabilities 5,049 7,058 Commitments and contingencies (Note 8) Stockholders’ equity: Common stock, $ 0.0001 par value per share, 800,000,000 shares authorized; 13,683,121 and 6,479,333 shares…
ARENA-BUSINESS-SOLUTIONS-GLOBAL-SPC-II-LTD ARENA-BUSINESS-SOLUTIONS-GLOBAL-SPC-II-LTD 62% ecurities were sold at a combined purchase price of $ 5.00 per share and accompanying March 26 Common Warrant, or $ 4.9999 per March 2026 Pre-Funded Warrant and accompanying March 2026 Common Warrant…
CAPITAL-RESOURCES CAPITAL-RESOURCES 62% 7 ) (1,489 ) (9 )% Loss from operations (4,048 ) (5,003 ) 955 19 % (17,836 ) (16,261 ) (1,575 ) (10 )% Other income / (expense): - % - % R&D tax incentive 82 421 (339 ) (81 )% 953 2,188 (1,235 ) (56 …
CORPORATE-INFORMATION-INCANNEX-HEALTHCARE-INC CORPORATE-INFORMATION-INCANNEX-HEALTHCARE-INC 62% ints raised by the Court of Justice of the European Union in its decision on a case known as Schrems II , which invalidated the previous EU-US Privacy Shield. Notably, the new obligations were geared…
CURVATURE-SECURITIES-LLC CURVATURE-SECURITIES-LLC 62% ecurities were sold at a combined purchase price of $ 5.00 per share and accompanying March 26 Common Warrant, or $ 4.9999 per March 2026 Pre-Funded Warrant and accompanying March 2026 Common Warrant…
EMERGING-GROWTH-COMPANY EMERGING-GROWTH-COMPANY 62% gross assets acquired is concentrated in a single identifiable asset or a group of similar identifiable assets. If this is the case, the acquired set is not deemed to be a business and is instead acc…
FORMATION-ACQUISITION-JURISDICTION-INCANNEX-HEAL FORMATION-ACQUISITION-JURISDICTION-INCANNEX-HEAL 62% ints raised by the Court of Justice of the European Union in its decision on a case known as Schrems II , which invalidated the previous EU-US Privacy Shield. Notably, the new obligations were geared…
SMALLER-REPORTING-COMPANY SMALLER-REPORTING-COMPANY 62% gross assets acquired is concentrated in a single identifiable asset or a group of similar identifiable assets. If this is the case, the acquired set is not deemed to be a business and is instead acc…
SUBSIDIARY-JURISDICTION-INCANNEX-HEALTHCARE-LIMI SUBSIDIARY-JURISDICTION-INCANNEX-HEALTHCARE-LIMI 62% - Total liabilities 5,049 7,058 Commitments and contingencies (Note 8) Stockholders’ equity: Common stock, $ 0.0001 par value per share, 800,000,000 shares authorized; 13,683,121 and 6,479,333 shares…
SUBSIDIARY-JURISDICTION-INCANNEX-HEALTHCARE-PTY- SUBSIDIARY-JURISDICTION-INCANNEX-HEALTHCARE-PTY- 62% current 163 113 Total current liabilities 5,620 2,550 Operating lease liabilities, non-current 210 408 Total liabilities 5,830 2,958 Commitments and contingencies (Note 8) Stockholders’ equity: Commo…
VICTORIA-AUSTRALIA-APIRX-PHARMACEUTICAL-USA-LLC VICTORIA-AUSTRALIA-APIRX-PHARMACEUTICAL-USA-LLC 62% current 163 113 Total current liabilities 5,620 2,550 Operating lease liabilities, non-current 210 408 Total liabilities 5,830 2,958 Commitments and contingencies (Note 8) Stockholders’ equity: Commo…
VICTORIA-AUSTRALIA-INCANNEX-PTY-LTD VICTORIA-AUSTRALIA-INCANNEX-PTY-LTD 62% ints raised by the Court of Justice of the European Union in its decision on a case known as Schrems II , which invalidated the previous EU-US Privacy Shield. Notably, the new obligations were geared…
VICTORIA-AUSTRALIA-PSYCHENNEX-PTY-LTD VICTORIA-AUSTRALIA-PSYCHENNEX-PTY-LTD 62% current 163 113 Total current liabilities 5,620 2,550 Operating lease liabilities, non-current 210 408 Total liabilities 5,830 2,958 Commitments and contingencies (Note 8) Stockholders’ equity: Commo…
WORKING-GROUP WORKING-GROUP 62% Cooperation Agreement between the European Union and the United Kingdom contains an Annex in relation to medicinal products with the objective of facilitating availability of medicines, promotion of …

Incannex Healthcare Inc. Debt Obligations

InstrumentDescriptionConfidenceEvidence
IXHL-DEBT-10408 Xbrl Convertible 90% xbrl convertible detail from xbrl 2025-06-30.
IXHL-DEBT-10407 Warrants outstanding: 453749 90% xbrl warrant detail from xbrl 2025-12-31.
IXHL-DEBT Debt stack $3.8M 90% Market cache reports total debt of $3.8M.

Incannex Healthcare Inc. Acquisitions

No acquisitions on recordNo completed or pending acquisitions found in our database for Incannex Healthcare Inc..

Incannex Healthcare Inc. Ownership

No ownership data on recordNo major institutional ownership relationships found in our database for Incannex Healthcare Inc..

Incannex Healthcare Inc. Extended Supply Chain Network

TickerNameChain IndexHopsRelationship Types
NVO Novo Nordisk A/S 100.00 1 ['customer', 'supplier']
ORANY ORANGE 100.00 1 ['customer', 'supplier']
AMZE Amaze Holdings, Inc. 50.00 2
AYTU Aytu BioPharma, Inc. 50.00 2
CYCN Cyclerion Therapeutics, Inc. 50.00 2
D Dominion Energy, Inc. 50.00 2
CRBP Corbus Pharmaceuticals Holdings, Inc. 50.00 2
DWTX Dogwood Therapeutics, Inc. 50.00 2
CANF Can-Fite BioPharma Ltd. 50.00 2
DFTX Definium Therapeutics, Inc. 50.00 2
CHUC Charlie's Holdings, Inc. 50.00 2
CLNE Clean Energy Fuels Corp. 50.00 2
FENC Fennec Pharmaceuticals Inc. 50.00 2
EQR Equity Residential 50.00 2
CNOB ConnectOne Bancorp, Inc. 50.00 2
DARE Daré Bioscience, Inc. 50.00 2
ESS Essex Property Trust, Inc. 50.00 2
ED Consolidated Edison, Inc. 50.00 2
CORT Corcept Therapeutics Incorporated 50.00 2
CPRX Catalyst Pharmaceuticals, Inc. 50.00 2
🔐
IXHL
Unlock IXHL Supply Chain Data
Verified relationships include:
A-G-P-ALLIANCE-GLOBAL-PARTNERSA-G-P-ALLIANCE-GLOBAL-PARTNERSSupplier90%
CONSULTANTSCONSULTANTSSupplier90%
NVONovo Nordisk A/SCustomer72%
NVONovo Nordisk A/SCustomer72%
+28 more relationships locked
Subscribe — View plans →